S 4905
118th Congress
Senate
Health
Cancer
Child health
Congressional oversight
Drug safety, medical device, and laboratory regulation
Drug therapy
Government information and archives
Government studies and investigations
Medical research
Prescription drugs
Research administration and funding
Innovation in Pediatric Drugs Act of 2024
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 31, 2024
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S5685-5686)
Jul 31, 2024
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S5685-5686)
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Lobbying activity
1
Cosponsors
1
Cite this page
U.S. Congress. (2026). S. 4905: Innovation in Pediatric Drugs Act of 2024. 118th Congress. Open America. https://openamerica.io/bill/118-S-4905/
"S. 4905: Innovation in Pediatric Drugs Act of 2024." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-4905/.
S. 4905, 118th Cong. (2026), https://openamerica.io/bill/118-S-4905/.
[S. 4905: Innovation in Pediatric Drugs Act of 2024](https://openamerica.io/bill/118-S-4905/)